Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

K.J. Harrington

ICRF Oncology Unit

Imperial College of Science

Technology and Medicine

Hammersmith Hospital

[email]@mayo.edu

Name/email consistency: high

[Claim this account]

Affiliations

ICRF Oncology Unit, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, UK. 2000 - 2001
Molecular Medicine Program, Mayo Clinic, Rochester, MN 55902, USA. 2000

References

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Harrington, K.J., Mohammadtaghi, S., Uster, P.S., Glass, D., Peters, A.M., Vile, R.G., Stewart, J.S. Clin. Cancer Res. (2001) [Pubmed]
Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model. Harrington, K.J., Rowlinson-Busza, G., Uster, P.S., Vile, R.G., Peters, A.M., Stewart, J.S. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes. Harrington, K.J., Rowlinson-Busza, G., Syrigos, K.N., Uster, P.S., Vile, R.G., Peters, A.M., Stewart, J.S. Int. J. Radiat. Oncol. Biol. Phys. (2001) [Pubmed]
Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer. Harrington, K.J., Lewanski, C.R., Northcote, A.D., Whittaker, J., Wellbank, H., Vile, R.G., Peters, A.M., Stewart, J.S. Ann. Oncol. (2001) [Pubmed]
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck. Harrington, K.J., Lewanski, C., Northcote, A.D., Whittaker, J., Peters, A.M., Vile, R.G., Stewart, J.S. Eur. J. Cancer (2001) [Pubmed]
Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development. Harrington, K.J., Lewanski, C.R., Stewart, J.S. Clin. Oncol. (R. Coll. Radiol) (2000) [Pubmed]
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development. Harrington, K.J., Lewanski, C.R., Stewart, J.S. Clin. Oncol. (R. Coll. Radiol) (2000) [Pubmed]
Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Harrington, K.J., Rowlinson-Busza, G., Syrigos, K.N., Uster, P.S., Vile, R.G., Stewart, J.S. Clin. Cancer Res. (2000) [Pubmed]
Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours. Harrington, K.J., Rowlinson-Busza, G., Uster, P.S., Stewart, J.S. Cancer Chemother. Pharmacol. (2000) [Pubmed]
Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model. Harrington, K.J., Rowlinson-Busza, G., Syrigos, K.N., Vile, R.G., Uster, P.S., Peters, A.M., Stewart, J.S. Clin. Cancer Res. (2000) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.